GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (OTCPK:AVCTF) » Definitions » Purchase Of Property, Plant, Equipment

AVCTF (Avacta Group) Purchase Of Property, Plant, Equipment : $-1.86 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avacta Group Purchase Of Property, Plant, Equipment?

Avacta Group's purchase of property, plant, equipment for the six months ended in Jun. 2024 was $-0.90 Mil. It means Avacta Group spent $0.90 Mil on purchasing property, plant, equipment. Avacta Group's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Jun. 2024 was $-1.86Mil.

Compared with last quarter ($-0.96 Mil in Dec. 2023 ), Avacta Group spent less money on purchasing property, plant, equipment in Jun. 2024 ($-0.90 Mil).


Avacta Group Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Avacta Group's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Purchase Of Property, Plant, Equipment Chart

Avacta Group Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Dec20 Dec21 Dec22 Dec23
Purchase Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.32 -1.72 -1.55 -0.88 -1.48

Avacta Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.56 -0.33 -0.51 -0.96 -0.90

Avacta Group Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avacta Group Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Avacta Group's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Avacta Group Business Description

Industry
Traded in Other Exchanges
Address
Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group Headlines

From GuruFocus

Avacta and LG Chem Life Sciences Expand Partnership

By Business Wire Business Wire 08-18-2020

Avacta Selects Second pre|CISION� Pro-drug Candidate for Development

By Business Wire Business Wire 01-18-2022

Avacta and Mologic Announce Commercial Partnership

By Business Wire Business Wire 02-08-2021

Avacta Launches SARS-CoV-2 BAMS Research Test

By Business Wire Business Wire 09-30-2020

Avacta Submits Clinical Trial Application for AVA6000 pro-doxorubixin

By Business Wire Business Wire 12-23-2020

First Patient Dosed in the US in Avacta's AVA6000 Phase 1 Clinical Study

By Business Wire Business Wire 04-27-2023